Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain

European Journal of Neuroscience

Volumn 26, Issue 9, 2007, Pages 2473-2480

  Di Fausto, Veronica ^a   Fiore, Marco ^a   Tirassa, Paola ^a   Lambiase, Alessandro ^a   Aloe, Luigi ^a  

^a CNR   (Italy)

Author keywords

Behaviour; ChAT; Ibotenic acid; NGF; Passive avoidance

Indexed keywords

CHOLINE ACETYLTRANSFERASE; EYE DROPS; IBOTENIC ACID; NERVE GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL STRUCTURE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVITY; FOREBRAIN; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL LESION; NONHUMAN; OLIVARY NUCLEUS; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; BASAL NUCLEUS OF MEYNERT; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DENERVATION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IBOTENIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NERVE DEGENERATION; NERVE GROWTH FACTOR; NERVE REGENERATION; NEURONS; OPHTHALMIC SOLUTIONS; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 35748957462     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05883.x     Document Type: Article

References (48)

1. Aloe, L. (1987) Intracerebral pretreatment with nerve growth factor prevents irreversible brain lesions in neonatal rats injected with ibotenic acid. Biotechnology, USA, 5, 1085 1086.
2. Aloe, L., Tirassa, P. Bracci-Laudiero, L. (2001) Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospective. Curr. Pharm. Des., 7, 113 123.
3. Ambati, J., Canakis, C.S., Miller, J.W., Gragoudas, E.S., Edwards, A., Weissgold, D.J., Kim, I., Delori, F.C. Adamis, A.P. (2000) Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci., 41, 1181 1185.
4. Barbacid, M. (1995) Structural and functional properties of the TRK family of neurotrophin receptors. Ann. N. Y. Acad. Sci., 766, 442 458.
5. von Bartheld, C.S., Williams, R., Lefcort, F., Clary, D.O., Reichardt, L.F. Bothwell, M. (1996) Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors. J. Neurosci., 16, 2995 3008.
6. Bocchini, V. Angeletti, P.U. (1969) The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl Acad. Sci. USA, 64, 787 794.
7. Bradbury, J. (2005) Hope for AD with NGF gene-therapy trial. Lancet Neurol., 4, 335.
8. Burke, M.A., Mobley, W.C., Cho, J., Wiegand, S.J., Lindsay, R.M., Mufson, E.J. Kordower, J.H. (1994) Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Exp. Neurol., 130, 178 195.
9. Charles, V., Mufson, E.J., Friden, P.M., Bartus, R.T. Kordower, J.H. (1996) Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res., 728, 193 203.
10. Chen, X.Q., Fawcett, J.R., Rahman, Y.E., Ala, T.A. Frey II, W.H. (1998) Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimers Dis., 1, 35 44.
11. Connor, B. Dragunow, M. (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev., 27, 1 39.
12. Cossette, P., Umbriaco, D., Zamar, N., Hamel, E. Descarries, L. (1993) Recovery of choline acetyltransferase activity without sprouting of the residual acetylcholine innervation in adult rat cerebral cortex after lesion of the nucleus basalis. Brain Res., 630, 195 206.
13. Coyle, J.T., Price, D.L. DeLong, M.R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science, 219, 1184 1190.
14. Cozzari, C. Hartman, B.K. (1980) Preparation of antibodies specific to choline acetyltransferase from bovine caudate nucleus and immunohistochemical localization of the enzyme. Proc. Natl Acad. Sci. USA, 77, 7453 7457.
15. Cuello, A.C. (1983) Brain Microdissection Techniques IBRO Handbook Series. John Wiley, Chicester.
16. Dixon, C.E., Flinn, P., Bao, J., Venya, R. Hayes, R.L. (1997) Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp. Neurol., 146, 479 490.
17. Dunnett, S.B., Everitt, B.J. Robbins, T.W. (1991) The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci., 14, 494 501.
18. Ebendal, T. (1992) Function and evolution in the NGF family and its receptors. J. Neurosci. Res., 32, 461 470.
19. Eriksdotter Jonhagen, M., Nordberg, A., Amberla, K., Backman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, Shigeta, M., Theodorsson, E., Viitanen, M., Winblad, B. Wahlund, L.O. (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 9, 246 257.
20. Fiore, M., Probert, L., Kollias, G., Akassoglou, K., Alleva, E. Aloe, L. (1996) Neurobehavioral alterations in developing transgenic mice expressing TNF-alpha in the brain. Brain Behav. Immun., 10, 126 138.
21. Fischer, W., Bjorklund, A., Chen, K. Gage, F.H. (1991) NGF improves spatial memory in aged rodents as a function of age. J. Neurosci., 11, 1889 1906.
22. Fonnum, F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem., 24, 407 409.
23. Franklin, K.B.J. Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA, USA.
24. Friden, P.M., Walus, L.R., Watson, P., Doctrow, S.R., Kozarich, J.W., Backman, C., Bergman, H., Hoffer, B., Bloom, F. Granholm, A.C. (1993) Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science, 259, 373 377.
25. Hagg, T., Fass-Holmes, B., Vahlsing, H.L., Manthorpe, M., Conner, J.M. Varon, S. (1989) Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res., 505, 29 38.
26. Holtzman, D.M., Li, Y., Chen, K., Gage, F.H., Epstein, C.J. Mobley, W.C. (1993) Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology, 43, 2668 2673.
27. Koevary, S.B. (2003) Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr. Drug. Metab., 4, 213 222.
28. Koevary, S.B., Nussey, J. Lake, S. (2002) Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats. Invest. Ophthalmol. Vis. Sci., 43, 797 804.
29. Kordower, J.H., Charles, V., Bayer, R., Bartus, R.T., Putney, S., Walus, L.R. Friden, P.M. (1994) Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc. Natl Acad. Sci. USA, 91, 9077 9080.
30. Lambiase, A., Manni, L., Bonini, S., Rama, P., Micera, A. Aloe, L. (2000) Nerve growth factor promotes corneal healing: structural, biochemical and molecular analyses on rat and human corneas. Invest. Ophthalmol. Vis. Sci., 41, 1063 1069.
31. Lambiase, A., Pagani, L., Di Fausto, V., Sposato, V., Coassin, M., Bonini, S. Aloe, L. (2007) Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res., 1127, 45 51.
32. Lambiase, A., Rama, P., Bonini, S., Caprioglio, G. Aloe, L. (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med., 338, 1174 1180.
33. Lambiase, A., Tirassa, P., Micera, A., Aloe, L. Bonini, S. (2005) Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest. Ophthalmol. Vis. Sci., 46, 3800 3806.
34. Lee, V.E. (1990) New direction in the optimization of ocular drug delivery. J. Ocul. Pharmacol., 6, 157 164.
35. Lenzi, L., Coassin, M., Lambiase, A., Bonini, S., Amendola, T. Aloe, L. (2005) Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vis. Res., 45, 1491 1500.
36. Levi-Montalcini, R. (1987) The nerve growth factor 35 years later. Science, 237, 1154 1162.
37. Liberini, P. Cuello, A.C. (1994) Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology. Rev. Neurosci., 5, 89 104.
38. Lorigados Pedre, L., Pavon Fuentes, N., Alvarez Gonzalez, L., McRae, A., Serrano Sanchez, T., Blanco Lescano, L. Macias Gonzalez, R. (2002) Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats. Brain Res., 952, 122 127.
39. Lorigados-Pedre, L. Bergado-Rosado, J. (2004) Nerve growth factor in neurodegeneration and neurorestorative therapy. Rev. Neurol., 38, 957 971.
40. Pizzo, D.P. Thal, L.J. (2004) Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery. Neuroscience, 124, 743 755.
41. Schoenwald, R.D., Deshpande, G.S., Rethwisch, D.G. Barfknecht, C.F. (1997) Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocul. Pharmacol. Ther., 13, 41 59.
42. Seiger, A., Nordberg, A., von Holst, H., Backman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., Lundqvist, H., Langstrom, B., Meyerson, B., Persson, A., Viitanen, M., Windblad, B. Olson, L. (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res., 57, 255 261.
43. Siegel, G.J. Chauhan, N.B. (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev., 33, 199 227.
44. Sofroniew, M.V., Howe, C.L. Mobley, W.C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci., 24, 1217 1281.
45. Tirassa, P., Aloe, L., Stenfors, C., Turrini, P. Lundeberg, T. (1999) Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis. Proc. Natl Acad. Sci. USA, 96, 6473 6477.
46. Triaca, V. Aloe, L. (2005) Neuronal markers expression of NGF-primed bone marrow cells (BMCs) transplanted in the brain of 6-hydroxydopamine and ibotenic acid lesioned littermate mice. Neurosci. Lett., 384, 82 86.
47. Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P.U.H.S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H.L., Ho, G., Tong, G., Potkin, S.G., Fallon, J., Hansen, L., Mufson, E.J., Kordower, J.H., Gall, C. Conner, J. (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med., 11, 551 555.
48. Winkler, J. Thal, L.J. (1995) Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Exp. Neurol., 136, 234 250.